Life Sciences Tools and Services
Company Overview of Hovione FarmaCiencia SA
Hovione FarmaCiencia SA, a contract formulation and manufacturing company, develops and manufactures active pharmaceutical ingredients (APIs), IMPs, and MPs for the pharmaceutical industry. It offers contract manufacturing services that include development and manufacture of drug substance; development and manufacturing services for particle engineering; development and manufacture of drugs; DPI formulation development; inhalation development services; and DPI devices. The company also provides API products, such as corticosteroids, tetracycline antibiotics, anticholinergics, contrast agents, and LABA products for various diseases that include asthma, COPD, acne, allergic rhinitis, and other...
Founded in 1959
Key Executives for Hovione FarmaCiencia SA
Chief Executive Officer and Director
Chief Financial Officer and Vice President of Finance
Head of Particle Design Sciences In New Jersey
Director of Corporate Communications
Vice President of Human Resources
Compensation as of Fiscal Year 2016.
Hovione FarmaCiencia SA Key Developments
Hovione Announces Expansion Plans of its New Jersey Facility
Jun 16 16
Hovione announced that it held on June 8th the official groundbreaking for the expansion of its New Jersey Facility in East Windsor, USA. The expansion will add an additional 30,600 ft² (2,843 m²) to the existing 24,000ft² (2,211m²) facility. It will introduce a new commercial spray dryer unit to complement the existing pilot unit and this installation will be specifically designed to handle potent drug substances (APIs). In addition the Hovione New Jersey facility will more than double its capacity to manufacture drug substance. The expansion is expected to add approximately 60 new jobs to the current workforce over the next three years.
Hovione Opens New Sales and Customer Support Office in Japan
Jun 6 16
Hovione announced the opening of its new sales and customer support office in Osaka, Japan. The new office underlines the importance of Japan for Hovione's business activities. Japan is a strategic market for Hovione where the company is growing both its off patent API and its contract manufacturing businesses. The new office will support customer relations and help in the development of new business within Japan, while reinforcing Hovione's global position. The new office is located at 20F Hankyu Grand Building 8-47 Kakuda-cho, Kita-ku Osaka 530-00178, Japan. The office offers a good accessibility and is centrally located in Osaka next to the main train station.
Hovione, Vertex Pharmaceuticals Partner in Continuous Manufacturing
Mar 10 16
Hovione on March 10, 2016 announced that it plans to host and operate a commercial-scale continuous manufacturing facility as part of an agreement with Vertex Pharmaceuticals. The facility will be installed in Hovione's New Jersey location, and Hovione expects the project to be complete by the end of 2017 to support the future manufacturing of Vertex's approved medicines. Continuous manufacturing represents an innovative shift from the traditional multi-step, multi-location batch production process, which can take up to four weeks or more to make commercial-ready medicines. With continuous manufacturing, raw materials used to produce oral medicines (tablets) are fed into a single, continuously running machine that includes real-time release testing and can create commercial-ready tablets in just one day. Continuous manufacturing is well suited for the production of precision medicines and those with breakthrough therapy designations where development timelines may be short and there are patients in urgent need of transformative new treatments. The new facility will include all facets of the continuous manufacturing process, including continuous blending, wet or dry granulation, fluid bed drying, tableting and coating operations. Spare capacity will be offered to third parties who are interested in manufacturing medicines through this process.
Similar Private Companies By Industry
Recent Private Companies Transactions